Effectiveness of COVID-19 vaccination in healthcare workers in Shiga Prefecture, Japan
This study, which included serological and cellular immunity tests, evaluated whether coronavirus disease 2019 (COVID-19) vaccination adequately protected healthcare workers (HCWs) from COVID-19. Serological investigations were conducted among 1600 HCWs (mean ± standard deviation, 7.4 ± 1.4 months a...
Saved in:
| Published in | Scientific reports Vol. 12; no. 1; pp. 17621 - 9 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
21.10.2022
Nature Publishing Group Nature Portfolio |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2045-2322 2045-2322 |
| DOI | 10.1038/s41598-022-22682-3 |
Cover
| Abstract | This study, which included serological and cellular immunity tests, evaluated whether coronavirus disease 2019 (COVID-19) vaccination adequately protected healthcare workers (HCWs) from COVID-19. Serological investigations were conducted among 1600 HCWs (mean ± standard deviation, 7.4 ± 1.4 months after the last COVID-19 vaccination). Anti-SARS-CoV-2 antibodies N-Ig, Spike-Ig (Roche), N-IgG, Spike-IgM, and -IgG (Abbott), were evaluated using a questionnaire of health condition. 161 HCWs were analyzed for cellular immunity using T-SPOT
®
SARS-CoV-2 kit before, and 52 HCWs were followed up until 138.3 ± 15.7 days after their third vaccination. Spike-IgG value was 954.4 ± 2282.6 AU/mL. Forty-nine of the 1600 HCWs (3.06%) had pre-existing SARS-CoV-2 infection. None of the infectious seropositive HCWs required hospitalization. T-SPOT value was 85.0 ± 84.2 SFU/10
6
cells before the third vaccination, which increased to 219.4 ± 230.4 SFU/10
6
cells immediately after, but attenuated later (to 111.1 ± 133.6 SFU/10
6
cells). Poor counts (< 40 SFU/10
6
cells) were present in 34.8% and 38.5% of HCWs before and after the third vaccination, respectively. Our findings provide insights into humoral and cellular immune responses to repeated COVID-19 vaccinations. COVID-19 vaccination was effective in protecting HCWs from serious illness during the original Wuhan-1, Alpha, Delta and also ongoing Omicron-predominance periods. However, repeated vaccinations using current vaccine versions may not induce sufficient cellular immunity in all HCWs. |
|---|---|
| AbstractList | Abstract This study, which included serological and cellular immunity tests, evaluated whether coronavirus disease 2019 (COVID-19) vaccination adequately protected healthcare workers (HCWs) from COVID-19. Serological investigations were conducted among 1600 HCWs (mean ± standard deviation, 7.4 ± 1.4 months after the last COVID-19 vaccination). Anti-SARS-CoV-2 antibodies N-Ig, Spike-Ig (Roche), N-IgG, Spike-IgM, and -IgG (Abbott), were evaluated using a questionnaire of health condition. 161 HCWs were analyzed for cellular immunity using T-SPOT® SARS-CoV-2 kit before, and 52 HCWs were followed up until 138.3 ± 15.7 days after their third vaccination. Spike-IgG value was 954.4 ± 2282.6 AU/mL. Forty-nine of the 1600 HCWs (3.06%) had pre-existing SARS-CoV-2 infection. None of the infectious seropositive HCWs required hospitalization. T-SPOT value was 85.0 ± 84.2 SFU/106 cells before the third vaccination, which increased to 219.4 ± 230.4 SFU/106 cells immediately after, but attenuated later (to 111.1 ± 133.6 SFU/106 cells). Poor counts (< 40 SFU/106 cells) were present in 34.8% and 38.5% of HCWs before and after the third vaccination, respectively. Our findings provide insights into humoral and cellular immune responses to repeated COVID-19 vaccinations. COVID-19 vaccination was effective in protecting HCWs from serious illness during the original Wuhan-1, Alpha, Delta and also ongoing Omicron-predominance periods. However, repeated vaccinations using current vaccine versions may not induce sufficient cellular immunity in all HCWs. This study, which included serological and cellular immunity tests, evaluated whether coronavirus disease 2019 (COVID-19) vaccination adequately protected healthcare workers (HCWs) from COVID-19. Serological investigations were conducted among 1600 HCWs (mean ± standard deviation, 7.4 ± 1.4 months after the last COVID-19 vaccination). Anti-SARS-CoV-2 antibodies N-Ig, Spike-Ig (Roche), N-IgG, Spike-IgM, and -IgG (Abbott), were evaluated using a questionnaire of health condition. 161 HCWs were analyzed for cellular immunity using T-SPOT ® SARS-CoV-2 kit before, and 52 HCWs were followed up until 138.3 ± 15.7 days after their third vaccination. Spike-IgG value was 954.4 ± 2282.6 AU/mL. Forty-nine of the 1600 HCWs (3.06%) had pre-existing SARS-CoV-2 infection. None of the infectious seropositive HCWs required hospitalization. T-SPOT value was 85.0 ± 84.2 SFU/10 6 cells before the third vaccination, which increased to 219.4 ± 230.4 SFU/10 6 cells immediately after, but attenuated later (to 111.1 ± 133.6 SFU/10 6 cells). Poor counts (< 40 SFU/10 6 cells) were present in 34.8% and 38.5% of HCWs before and after the third vaccination, respectively. Our findings provide insights into humoral and cellular immune responses to repeated COVID-19 vaccinations. COVID-19 vaccination was effective in protecting HCWs from serious illness during the original Wuhan-1, Alpha, Delta and also ongoing Omicron-predominance periods. However, repeated vaccinations using current vaccine versions may not induce sufficient cellular immunity in all HCWs. This study, which included serological and cellular immunity tests, evaluated whether coronavirus disease 2019 (COVID-19) vaccination adequately protected healthcare workers (HCWs) from COVID-19. Serological investigations were conducted among 1600 HCWs (mean ± standard deviation, 7.4 ± 1.4 months after the last COVID-19 vaccination). Anti-SARS-CoV-2 antibodies N-Ig, Spike-Ig (Roche), N-IgG, Spike-IgM, and -IgG (Abbott), were evaluated using a questionnaire of health condition. 161 HCWs were analyzed for cellular immunity using T-SPOT SARS-CoV-2 kit before, and 52 HCWs were followed up until 138.3 ± 15.7 days after their third vaccination. Spike-IgG value was 954.4 ± 2282.6 AU/mL. Forty-nine of the 1600 HCWs (3.06%) had pre-existing SARS-CoV-2 infection. None of the infectious seropositive HCWs required hospitalization. T-SPOT value was 85.0 ± 84.2 SFU/10 cells before the third vaccination, which increased to 219.4 ± 230.4 SFU/10 cells immediately after, but attenuated later (to 111.1 ± 133.6 SFU/10 cells). Poor counts (< 40 SFU/10 cells) were present in 34.8% and 38.5% of HCWs before and after the third vaccination, respectively. Our findings provide insights into humoral and cellular immune responses to repeated COVID-19 vaccinations. COVID-19 vaccination was effective in protecting HCWs from serious illness during the original Wuhan-1, Alpha, Delta and also ongoing Omicron-predominance periods. However, repeated vaccinations using current vaccine versions may not induce sufficient cellular immunity in all HCWs. This study, which included serological and cellular immunity tests, evaluated whether coronavirus disease 2019 (COVID-19) vaccination adequately protected healthcare workers (HCWs) from COVID-19. Serological investigations were conducted among 1600 HCWs (mean ± standard deviation, 7.4 ± 1.4 months after the last COVID-19 vaccination). Anti-SARS-CoV-2 antibodies N-Ig, Spike-Ig (Roche), N-IgG, Spike-IgM, and -IgG (Abbott), were evaluated using a questionnaire of health condition. 161 HCWs were analyzed for cellular immunity using T-SPOT® SARS-CoV-2 kit before, and 52 HCWs were followed up until 138.3 ± 15.7 days after their third vaccination. Spike-IgG value was 954.4 ± 2282.6 AU/mL. Forty-nine of the 1600 HCWs (3.06%) had pre-existing SARS-CoV-2 infection. None of the infectious seropositive HCWs required hospitalization. T-SPOT value was 85.0 ± 84.2 SFU/106 cells before the third vaccination, which increased to 219.4 ± 230.4 SFU/106 cells immediately after, but attenuated later (to 111.1 ± 133.6 SFU/106 cells). Poor counts (< 40 SFU/106 cells) were present in 34.8% and 38.5% of HCWs before and after the third vaccination, respectively. Our findings provide insights into humoral and cellular immune responses to repeated COVID-19 vaccinations. COVID-19 vaccination was effective in protecting HCWs from serious illness during the original Wuhan-1, Alpha, Delta and also ongoing Omicron-predominance periods. However, repeated vaccinations using current vaccine versions may not induce sufficient cellular immunity in all HCWs.This study, which included serological and cellular immunity tests, evaluated whether coronavirus disease 2019 (COVID-19) vaccination adequately protected healthcare workers (HCWs) from COVID-19. Serological investigations were conducted among 1600 HCWs (mean ± standard deviation, 7.4 ± 1.4 months after the last COVID-19 vaccination). Anti-SARS-CoV-2 antibodies N-Ig, Spike-Ig (Roche), N-IgG, Spike-IgM, and -IgG (Abbott), were evaluated using a questionnaire of health condition. 161 HCWs were analyzed for cellular immunity using T-SPOT® SARS-CoV-2 kit before, and 52 HCWs were followed up until 138.3 ± 15.7 days after their third vaccination. Spike-IgG value was 954.4 ± 2282.6 AU/mL. Forty-nine of the 1600 HCWs (3.06%) had pre-existing SARS-CoV-2 infection. None of the infectious seropositive HCWs required hospitalization. T-SPOT value was 85.0 ± 84.2 SFU/106 cells before the third vaccination, which increased to 219.4 ± 230.4 SFU/106 cells immediately after, but attenuated later (to 111.1 ± 133.6 SFU/106 cells). Poor counts (< 40 SFU/106 cells) were present in 34.8% and 38.5% of HCWs before and after the third vaccination, respectively. Our findings provide insights into humoral and cellular immune responses to repeated COVID-19 vaccinations. COVID-19 vaccination was effective in protecting HCWs from serious illness during the original Wuhan-1, Alpha, Delta and also ongoing Omicron-predominance periods. However, repeated vaccinations using current vaccine versions may not induce sufficient cellular immunity in all HCWs. This study, which included serological and cellular immunity tests, evaluated whether coronavirus disease 2019 (COVID-19) vaccination adequately protected healthcare workers (HCWs) from COVID-19. Serological investigations were conducted among 1600 HCWs (mean ± standard deviation, 7.4 ± 1.4 months after the last COVID-19 vaccination). Anti-SARS-CoV-2 antibodies N-Ig, Spike-Ig (Roche), N-IgG, Spike-IgM, and -IgG (Abbott), were evaluated using a questionnaire of health condition. 161 HCWs were analyzed for cellular immunity using T-SPOT® SARS-CoV-2 kit before, and 52 HCWs were followed up until 138.3 ± 15.7 days after their third vaccination. Spike-IgG value was 954.4 ± 2282.6 AU/mL. Forty-nine of the 1600 HCWs (3.06%) had pre-existing SARS-CoV-2 infection. None of the infectious seropositive HCWs required hospitalization. T-SPOT value was 85.0 ± 84.2 SFU/106 cells before the third vaccination, which increased to 219.4 ± 230.4 SFU/106 cells immediately after, but attenuated later (to 111.1 ± 133.6 SFU/106 cells). Poor counts (< 40 SFU/106 cells) were present in 34.8% and 38.5% of HCWs before and after the third vaccination, respectively. Our findings provide insights into humoral and cellular immune responses to repeated COVID-19 vaccinations. COVID-19 vaccination was effective in protecting HCWs from serious illness during the original Wuhan-1, Alpha, Delta and also ongoing Omicron-predominance periods. However, repeated vaccinations using current vaccine versions may not induce sufficient cellular immunity in all HCWs. This study, which included serological and cellular immunity tests, evaluated whether coronavirus disease 2019 (COVID-19) vaccination adequately protected healthcare workers (HCWs) from COVID-19. Serological investigations were conducted among 1600 HCWs (mean ± standard deviation, 7.4 ± 1.4 months after the last COVID-19 vaccination). Anti-SARS-CoV-2 antibodies N-Ig, Spike-Ig (Roche), N-IgG, Spike-IgM, and -IgG (Abbott), were evaluated using a questionnaire of health condition. 161 HCWs were analyzed for cellular immunity using T-SPOT® SARS-CoV-2 kit before, and 52 HCWs were followed up until 138.3 ± 15.7 days after their third vaccination. Spike-IgG value was 954.4 ± 2282.6 AU/mL. Forty-nine of the 1600 HCWs (3.06%) had pre-existing SARS-CoV-2 infection. None of the infectious seropositive HCWs required hospitalization. T-SPOT value was 85.0 ± 84.2 SFU/106 cells before the third vaccination, which increased to 219.4 ± 230.4 SFU/106 cells immediately after, but attenuated later (to 111.1 ± 133.6 SFU/106 cells). Poor counts (< 40 SFU/106 cells) were present in 34.8% and 38.5% of HCWs before and after the third vaccination, respectively. Our findings provide insights into humoral and cellular immune responses to repeated COVID-19 vaccinations. COVID-19 vaccination was effective in protecting HCWs from serious illness during the original Wuhan-1, Alpha, Delta and also ongoing Omicron-predominance periods. However, repeated vaccinations using current vaccine versions may not induce sufficient cellular immunity in all HCWs. |
| ArticleNumber | 17621 |
| Author | Kume, Shinji Kakuno, Fumihiko Chano, Tokuhiro Kita, Hiroko Ikemoto, Toshiyuki Morita, Shin-ya Suzuki, Tomoyuki Fujimura, Hirokazu Yamashita, Tomoko |
| Author_xml | – sequence: 1 givenname: Tokuhiro surname: Chano fullname: Chano, Tokuhiro email: chano@belle.shiga-med.ac.jp organization: Department of Clinical Laboratory Medicine, Shiga University of Medical Science Hospital – sequence: 2 givenname: Tomoko surname: Yamashita fullname: Yamashita, Tomoko organization: Department of Clinical Laboratory Medicine, Shiga University of Medical Science Hospital – sequence: 3 givenname: Hirokazu surname: Fujimura fullname: Fujimura, Hirokazu organization: Department of Clinical Laboratory Medicine, Shiga University of Medical Science Hospital – sequence: 4 givenname: Hiroko surname: Kita fullname: Kita, Hiroko organization: Department of Clinical Laboratory Medicine, Shiga University of Medical Science Hospital – sequence: 5 givenname: Toshiyuki surname: Ikemoto fullname: Ikemoto, Toshiyuki organization: Department of Clinical Laboratory Medicine, Shiga University of Medical Science Hospital – sequence: 6 givenname: Shinji surname: Kume fullname: Kume, Shinji organization: Department of Nephrology, Shiga University of Medical Science Hospital – sequence: 7 givenname: Shin-ya surname: Morita fullname: Morita, Shin-ya organization: Department of Pharmacy, Shiga University of Medical Science Hospital – sequence: 8 givenname: Tomoyuki surname: Suzuki fullname: Suzuki, Tomoyuki organization: Shiga Prefecture Administration – sequence: 9 givenname: Fumihiko surname: Kakuno fullname: Kakuno, Fumihiko organization: Shiga Prefecture Administration |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36271136$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkUtv1DAUhSNURB_0D7BAkdiwIOB3nA0SGgoMqlQkoFvrxrFnPGTsqZ1M1X9fz4PSdlFxN7auz_10fO5xceCDN0XxCqP3GFH5ITHMG1khQipChCQVfVYcEcR4RSghB_fuh8VpSguUi5OG4eZFcUgFqTGm4qi4PLPW6MGtjTcplcGWk4vL6ecKN-UatHYeBhd86Xw5N9APcw3RlNch_jExbbo_524G5Y9oNpQxmnfld1iBf1k8t9Anc7o_T4rfX85-Tb5V5xdfp5NP55UWHA2VRTUHq42owdak6ZgFadoOd1wCE7o1lmItMePUslZabFEDAqPaYI46yVp6Ukx33C7AQq2iW0K8UQGc2jZCnCmIg9O9UYgzTIzU0lLBaAeSSoYoaTvISNxBZtEda_QruLmGvr8DYqQ2oatd6CqHrrahK5qnPu6mVmO7NJ02fojQP7Dy8MW7uZqFtWq4FA0XGfB2D4jhajRpUEuXtOl78CaMSZGa1II2ubL0zSPpIozR54C3KowlpRvV6_uO7qz8XXoWyJ1Ax5BSXp3SbtjuORt0_dO_JY9G_yuifbApi_3MxH-2n5i6BR1H4Bw |
| CitedBy_id | crossref_primary_10_1177_25151355231181744 crossref_primary_10_1186_s13256_024_04889_2 crossref_primary_10_1186_s12879_024_09001_z |
| Cites_doi | 10.1056/NEJMoa2114228 10.1038/s41586-022-04465-y 10.1016/s2213-2600(22)00101-1 10.1016/j.diagmicrobio.2021.115370 10.1056/NEJMoa2114583 10.1038/s41586-022-04778-y 10.1016/j.lanepe.2021.100208 10.1016/s0140-6736(21)00501-8 10.1016/s0140-6736(21)00502-x 10.1126/sciimmunol.abo2202 10.3390/ijerph18073786 10.1038/bmt.2012.244 10.1016/j.cell.2022.04.009 10.1093/infdis/jiab584 10.1101/2020.11.02.20222778 10.1016/s0140-6736(21)01642-1 10.1038/s41591-022-01700-x 10.1371/journal.pone.0270334 10.1038/s41590-021-01122-w 10.1038/s41586-022-04460-3 10.1016/s1473-3099(22)00271-7 10.3390/v14040802 10.3390/jcm9123989 10.1038/s42003-021-02885-6 10.1093/cid/ciab1041 10.1136/bmj.m3944 10.1101/2020.04.29.20085449 10.1016/j.diagmicrobio.2021.115403 10.1016/j.diagmicrobio.2021.115313 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 2022. The Author(s). The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.1038/s41598-022-22682-3 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database Proquest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 6 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-2322 |
| EndPage | 9 |
| ExternalDocumentID | oai_doaj_org_article_05412e8c8f3643da8384032bdaa611da 10.1038/s41598-022-22682-3 PMC9586956 36271136 10_1038_s41598_022_22682_3 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GrantInformation_xml | – fundername: Shiga Prefecture Governor grantid: PT330033 – fundername: ; grantid: PT330033 |
| GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT PJZUB PPXIY PQGLB PUEGO CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PKEHL PQEST PQUKI Q9U 7X8 5PM ADTOC EJD IPNFZ RIG UNPAY |
| ID | FETCH-LOGICAL-c650t-f075afce67af729d4fa8ebd1d58a46cbef31c81453f4b8f1f09a6107e150d84b3 |
| IEDL.DBID | M48 |
| ISSN | 2045-2322 |
| IngestDate | Fri Oct 03 12:43:29 EDT 2025 Sun Oct 26 03:41:46 EDT 2025 Tue Sep 30 17:18:17 EDT 2025 Thu Oct 02 11:11:22 EDT 2025 Tue Oct 07 07:56:11 EDT 2025 Thu Jan 02 22:53:41 EST 2025 Wed Oct 01 01:37:48 EDT 2025 Thu Apr 24 23:06:53 EDT 2025 Fri Feb 21 02:39:21 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2022. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c650t-f075afce67af729d4fa8ebd1d58a46cbef31c81453f4b8f1f09a6107e150d84b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-022-22682-3 |
| PMID | 36271136 |
| PQID | 2727118339 |
| PQPubID | 2041939 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_05412e8c8f3643da8384032bdaa611da unpaywall_primary_10_1038_s41598_022_22682_3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9586956 proquest_miscellaneous_2727639999 proquest_journals_2727118339 pubmed_primary_36271136 crossref_citationtrail_10_1038_s41598_022_22682_3 crossref_primary_10_1038_s41598_022_22682_3 springer_journals_10_1038_s41598_022_22682_3 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-10-21 |
| PublicationDateYYYYMMDD | 2022-10-21 |
| PublicationDate_xml | – month: 10 year: 2022 text: 2022-10-21 day: 21 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2022 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Muecksch (CR24) 2022; 607 Kanda (CR15) 2013; 48 Liu (CR28) 2022; 603 CR17 Levin (CR21) 2021; 385 GeurtsvanKessel (CR29) 2022; 7 Moss (CR5) 2022; 23 Stouten (CR16) 2022; 14 Lu (CR26) 2021 Shrotri (CR20) 2021; 398 Prendecki (CR13) 2021; 397 Yoshihara (CR1) 2021; 18 Gilboa (CR25) 2021 Schaffner (CR10) 2020; 9 Keeton (CR27) 2022; 603 Tartof (CR7) 2022 Karlsson, Fraenkel (CR18) 2020; 371 CR4 Tanis (CR8) 2021; 100 Takita (CR2) 2020 Goldberg (CR22) 2021; 385 Gao (CR31) 2022; 28 Chano (CR3) 2022; 17 Wyllie (CR14) 2020 Goel (CR30) 2022; 185 Manisty (CR11) 2021; 397 Kubota (CR12) 2021; 100 Schallier (CR9) 2021; 100 Naaber (CR19) 2021 Shimizu (CR23) 2021; 4 Munro (CR6) 2022 SY Tartof (22682_CR7) 2022 K Kubota (22682_CR12) 2021; 100 U Karlsson (22682_CR18) 2020; 371 M Prendecki (22682_CR13) 2021; 397 M Shrotri (22682_CR20) 2021; 398 P Naaber (22682_CR19) 2021 RR Goel (22682_CR30) 2022; 185 Y Gao (22682_CR31) 2022; 28 M Takita (22682_CR2) 2020 Y Goldberg (22682_CR22) 2021; 385 CH GeurtsvanKessel (22682_CR29) 2022; 7 C Manisty (22682_CR11) 2021; 397 K Shimizu (22682_CR23) 2021; 4 T Yoshihara (22682_CR1) 2021; 18 J Tanis (22682_CR8) 2021; 100 Y Kanda (22682_CR15) 2013; 48 V Stouten (22682_CR16) 2022; 14 L Lu (22682_CR26) 2021 M Gilboa (22682_CR25) 2021 T Chano (22682_CR3) 2022; 17 P Moss (22682_CR5) 2022; 23 D Wyllie (22682_CR14) 2020 EG Levin (22682_CR21) 2021; 385 J Liu (22682_CR28) 2022; 603 APS Munro (22682_CR6) 2022 F Muecksch (22682_CR24) 2022; 607 22682_CR4 R Keeton (22682_CR27) 2022; 603 A Schaffner (22682_CR10) 2020; 9 22682_CR17 A Schallier (22682_CR9) 2021; 100 |
| References_xml | – volume: 385 year: 2021 ident: CR22 article-title: Waning immunity after the BNT162b2 vaccine in Israel publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2114228 – volume: 603 start-page: 493 year: 2022 end-page: 496 ident: CR28 article-title: Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron publication-title: Nature doi: 10.1038/s41586-022-04465-y – year: 2022 ident: CR7 article-title: Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study publication-title: Lancet Respir. Med. doi: 10.1016/s2213-2600(22)00101-1 – volume: 100 year: 2021 ident: CR12 article-title: Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays publication-title: Diagn. Microbiol. Infect. Dis. doi: 10.1016/j.diagmicrobio.2021.115370 – volume: 385 year: 2021 ident: CR21 article-title: Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2114583 – volume: 607 start-page: 128 year: 2022 end-page: 134 ident: CR24 article-title: Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost publication-title: Nature doi: 10.1038/s41586-022-04778-y – ident: CR4 – year: 2021 ident: CR19 article-title: Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study publication-title: Lancet Reg. Health Eur. doi: 10.1016/j.lanepe.2021.100208 – volume: 397 start-page: 1057 year: 2021 end-page: 1058 ident: CR11 article-title: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals publication-title: The Lancet doi: 10.1016/s0140-6736(21)00501-8 – volume: 397 start-page: 1178 year: 2021 end-page: 1181 ident: CR13 article-title: Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine publication-title: The Lancet doi: 10.1016/s0140-6736(21)00502-x – volume: 7 start-page: eabo2202 year: 2022 ident: CR29 article-title: Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.abo2202 – volume: 18 start-page: 3786 year: 2021 ident: CR1 article-title: SARS-CoV-2 seroprevalence among healthcare workers in general hospitals and clinics in Japan publication-title: Int. J. Environ. Res. Public Health doi: 10.3390/ijerph18073786 – volume: 48 start-page: 452 year: 2013 end-page: 458 ident: CR15 article-title: Investigation of the freely available easy-to-use software 'EZR' for medical statistics publication-title: Bone Marrow Transplant. doi: 10.1038/bmt.2012.244 – volume: 185 start-page: 1875 year: 2022 end-page: 1887.e1878 ident: CR30 article-title: Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine publication-title: Cell doi: 10.1016/j.cell.2022.04.009 – year: 2021 ident: CR25 article-title: Early immunogenicity and safety of the third dose of BNT162b2 mRNA Covid-19 vaccine among adults older than 60 years; real world experience publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiab584 – year: 2020 ident: CR14 article-title: SARS-CoV-2 responsive T cell numbers are associated with protection from COVID-19: A prospective cohort study in keyworkers publication-title: medRxiv doi: 10.1101/2020.11.02.20222778 – volume: 398 start-page: 385 year: 2021 end-page: 387 ident: CR20 article-title: Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 publication-title: The Lancet doi: 10.1016/s0140-6736(21)01642-1 – volume: 28 start-page: 472 year: 2022 end-page: 476 ident: CR31 article-title: Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant publication-title: Nat. Med. doi: 10.1038/s41591-022-01700-x – volume: 17 year: 2022 ident: CR3 article-title: Serology suggests adequate safety measures to protect healthcare workers from COVID-19 in Shiga Prefecture, Japan publication-title: PLoS One doi: 10.1371/journal.pone.0270334 – volume: 23 start-page: 186 year: 2022 end-page: 193 ident: CR5 article-title: The T cell immune response against SARS-CoV-2 publication-title: Nat. Immunol. doi: 10.1038/s41590-021-01122-w – volume: 603 start-page: 488 year: 2022 end-page: 492 ident: CR27 article-title: T cell responses to SARS-CoV-2 spike cross-recognize Omicron publication-title: Nature doi: 10.1038/s41586-022-04460-3 – year: 2022 ident: CR6 article-title: Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): A multicentre, blinded, phase 2, randomised trial publication-title: Lancet Infect. Dis. doi: 10.1016/s1473-3099(22)00271-7 – volume: 14 start-page: 802 year: 2022 ident: CR16 article-title: Incidence and risk factors of COVID-19 vaccine breakthrough infections: A prospective cohort study in Belgium publication-title: Viruses doi: 10.3390/v14040802 – ident: CR17 – volume: 9 start-page: 3989 year: 2020 ident: CR10 article-title: Characterization of a pan-immunoglobulin assay quantifying antibodies directed against the receptor binding domain of the SARS-CoV-2 S1-subunit of the spike protein: A population-based study publication-title: J. Clin. Med. doi: 10.3390/jcm9123989 – volume: 4 start-page: 1365 year: 2021 ident: CR23 article-title: Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2 publication-title: Commun. Biol. doi: 10.1038/s42003-021-02885-6 – year: 2021 ident: CR26 article-title: Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciab1041 – volume: 371 year: 2020 ident: CR18 article-title: Covid-19: Risks to healthcare workers and their families publication-title: BMJ doi: 10.1136/bmj.m3944 – year: 2020 ident: CR2 article-title: Preliminary results of seroprevalence of SARS-CoV-2 at community clinics in Tokyo publication-title: medRxiv doi: 10.1101/2020.04.29.20085449 – volume: 100 year: 2021 ident: CR9 article-title: Assay dependence of long-term kinetics of SARS-CoV-2 antibodies publication-title: Diagn. Microbiol. Infect. Dis. doi: 10.1016/j.diagmicrobio.2021.115403 – volume: 100 year: 2021 ident: CR8 article-title: Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays publication-title: Diagn. Microbiol. Infect. Dis. doi: 10.1016/j.diagmicrobio.2021.115313 – volume: 18 start-page: 3786 year: 2021 ident: 22682_CR1 publication-title: Int. J. Environ. Res. Public Health doi: 10.3390/ijerph18073786 – year: 2020 ident: 22682_CR14 publication-title: medRxiv doi: 10.1101/2020.11.02.20222778 – year: 2022 ident: 22682_CR6 publication-title: Lancet Infect. Dis. doi: 10.1016/s1473-3099(22)00271-7 – volume: 371 year: 2020 ident: 22682_CR18 publication-title: BMJ doi: 10.1136/bmj.m3944 – volume: 17 year: 2022 ident: 22682_CR3 publication-title: PLoS One doi: 10.1371/journal.pone.0270334 – year: 2021 ident: 22682_CR19 publication-title: Lancet Reg. Health Eur. doi: 10.1016/j.lanepe.2021.100208 – volume: 23 start-page: 186 year: 2022 ident: 22682_CR5 publication-title: Nat. Immunol. doi: 10.1038/s41590-021-01122-w – volume: 385 year: 2021 ident: 22682_CR21 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2114583 – volume: 28 start-page: 472 year: 2022 ident: 22682_CR31 publication-title: Nat. Med. doi: 10.1038/s41591-022-01700-x – volume: 4 start-page: 1365 year: 2021 ident: 22682_CR23 publication-title: Commun. Biol. doi: 10.1038/s42003-021-02885-6 – volume: 9 start-page: 3989 year: 2020 ident: 22682_CR10 publication-title: J. Clin. Med. doi: 10.3390/jcm9123989 – volume: 603 start-page: 488 year: 2022 ident: 22682_CR27 publication-title: Nature doi: 10.1038/s41586-022-04460-3 – volume: 100 year: 2021 ident: 22682_CR9 publication-title: Diagn. Microbiol. Infect. Dis. doi: 10.1016/j.diagmicrobio.2021.115403 – volume: 397 start-page: 1178 year: 2021 ident: 22682_CR13 publication-title: The Lancet doi: 10.1016/s0140-6736(21)00502-x – volume: 14 start-page: 802 year: 2022 ident: 22682_CR16 publication-title: Viruses doi: 10.3390/v14040802 – year: 2022 ident: 22682_CR7 publication-title: Lancet Respir. Med. doi: 10.1016/s2213-2600(22)00101-1 – volume: 603 start-page: 493 year: 2022 ident: 22682_CR28 publication-title: Nature doi: 10.1038/s41586-022-04465-y – volume: 100 year: 2021 ident: 22682_CR12 publication-title: Diagn. Microbiol. Infect. Dis. doi: 10.1016/j.diagmicrobio.2021.115370 – year: 2021 ident: 22682_CR26 publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciab1041 – year: 2020 ident: 22682_CR2 publication-title: medRxiv doi: 10.1101/2020.04.29.20085449 – volume: 385 year: 2021 ident: 22682_CR22 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2114228 – volume: 100 year: 2021 ident: 22682_CR8 publication-title: Diagn. Microbiol. Infect. Dis. doi: 10.1016/j.diagmicrobio.2021.115313 – ident: 22682_CR4 – volume: 48 start-page: 452 year: 2013 ident: 22682_CR15 publication-title: Bone Marrow Transplant. doi: 10.1038/bmt.2012.244 – volume: 607 start-page: 128 year: 2022 ident: 22682_CR24 publication-title: Nature doi: 10.1038/s41586-022-04778-y – volume: 7 start-page: eabo2202 year: 2022 ident: 22682_CR29 publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.abo2202 – volume: 397 start-page: 1057 year: 2021 ident: 22682_CR11 publication-title: The Lancet doi: 10.1016/s0140-6736(21)00501-8 – volume: 185 start-page: 1875 year: 2022 ident: 22682_CR30 publication-title: Cell doi: 10.1016/j.cell.2022.04.009 – volume: 398 start-page: 385 year: 2021 ident: 22682_CR20 publication-title: The Lancet doi: 10.1016/s0140-6736(21)01642-1 – ident: 22682_CR17 – year: 2021 ident: 22682_CR25 publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiab584 |
| SSID | ssj0000529419 |
| Score | 2.3972106 |
| Snippet | This study, which included serological and cellular immunity tests, evaluated whether coronavirus disease 2019 (COVID-19) vaccination adequately protected... Abstract This study, which included serological and cellular immunity tests, evaluated whether coronavirus disease 2019 (COVID-19) vaccination adequately... |
| SourceID | doaj unpaywall pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 17621 |
| SubjectTerms | 631/250/255/2514 692/699/255/2514 Cell-mediated immunity Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 Vaccines Health care Health Personnel Humanities and Social Sciences Humans Immune response (humoral) Immunoglobulin G Immunoglobulin M Japan - epidemiology Medical personnel multidisciplinary SARS-CoV-2 Science Science (multidisciplinary) Serology Severe acute respiratory syndrome coronavirus 2 Vaccination |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hShVwQC3PQEFG4sZGjR-b2EcorUolHhK06s2yHbu70ipb0V1Q_z1jOxt2BSocuOTgOJEzj8w3fnwD8CqSSOWptxovggZfWs9CaRvHGvQnE3g8KPzhY318Kk7Ox-drpb7inrBMD5wFt4-QgjIvnQwcg2drJMeUhDPbGoNvbxM0qqRaS6YyqzdTgqr-lEzF5f4VRqp4mgxzL0QcCCv5RiRKhP1_Qpm_b5YcVkzvwu1ld2muf5jZbC0oHe3AvR5Nkjf5K3bhlu_uw3auL3n9AM4yN3H_QyPzQA4-nb1_V1JFvhvnpnkmkEw7Mhm2gZG4UwsxYWz9MpleGPI5liJJKw0jcoKxtXsIp0eHXw-Oy76QQukQgC3KgLjABOfrxgQE060IRnrb0nYsjaid9YFTJ6kY8yCsDDRUCoVbNR7RYiuF5Y9gq5t3_gkQ0xjjbEVd23KhpFXCV5aKwOoEF0MBdCVU7XqW8VjsYqbTajeXOitCoyJ0UoTmBbwenrnMHBs39n4bdTX0jPzYqQGtRvdWo_9mNQXsrTSte6e90gyxHOZbnKsCXg630d3iGorp_HyZ-0RQp7DP42wYw0gQCzSxRE4BzYbJbAx18043nSRKbzWWNWaqBYxWxvVrWDeJYjQY4D9I7un_kNwzuMOiE2H4ZnQPthbflv454rKFfZFc8CfWnzAR priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LbxMxEB6VVAh6QLwKSwsyEjeyarx2dr0HVNGXSiVCBbTqzfKziRTthjYp6r9nvK82AkVc9mB7Jdsz4_nssb8B-BBIpOqjtxQ_nHoXa5f4WGcmydCelGfhofDXUXp8xk8uhhdrMGrfwoRrle2aWC3UtjThjHwnQUeLYJixfHf2Kw5Zo0J0tU2hoZrUCvZTRTH2ANaTwIzVg_W9w9Hp9-7UJcS1OM2b1zMDJnau0YOFV2a4J0MkgnCTLXmoisj_X-jz70uUXSR1Ax4tipm6_a2m03vO6ugpPGlQJvlcq8UzWHPFc3hY5528fQHnNWdxs9CR0pP9b-dfDmKakxsc46Q-ISSTgoy762Ek3OBCrBhKf4wnl4qchhQlVQSiT07Q5xYv4ezo8Of-cdwkWIgNArN57BEvKG9cmimPINtyr4TTltqhUDw12nlGjaB8yDzXwlM_yBXCrcwhirSCa7YJvaIs3GsgKlPK6AE11jKeC51zN9CU-yStYKSPgLaTKk3DPh6SYExlFQVnQtaCkCgIWQlCsgg-dv_Mau6Nla33gqy6loE3uyoory5lY4YSASpNnDDCM4RiVgmGG1yWaKtwYNSqCLZbScvGmK_lnepF8L6rRjMMsRVVuHJRtwlgL8c2r2rF6HqCGCELqXMiyJZUZqmryzXFZFxRfedDkeIONoJ-q1x33Vo1Ff1OAf9j5t6sHvQWPE6CeaDDTug29OZXC_cWkdhcv2vM6w_8YS6A priority: 102 providerName: ProQuest – databaseName: HAS SpringerNature Open Access 2022 dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlZ3dT9swEMBPrGja9oD2BcuAyZP2tkarYzdxHgsMsUqDSQzEm-VPWqlK0Wg38d_vHKeBiAmxlz4kduX67no_--w7gE8hiVTcesvxg1PvUu0yn-rCZAXak_IsXBT-fpwfnfHxxfBiDfqruzCd-H2duvsaXUy4BoaLJkQF5EH2BNYFKqbowfpoND4dt3sqIWrFadncjcHuX-537vifOk3_v9jy_hHJNk76Ap4tqyt180fNZndc0eFL2GgYkoyi0F_Bmqtew9NYVfLmDZzHjMTN3xiZe7J_cv7tIKUl-a2Mmcb9PzKtyKQ9_EXC-SwkwfD0dDK9VORHKEBSxxf6ZIwetXoLZ4dff-4fpU35hNQgdi1SjzSgvHF5oTwitOVeCacttUOheG6084waQfmQea6Fp35QKoSpwiEjWsE124ReNa_cOyCqUMroATXWMl4KXXI30JT7LK8h0SdAV5MqTZNbPJS4mMk6xs2EjIKQKAhZC0KyBD63fa5iZo0HW-8FWbUtQ1bs-gEqi2yMTCJ-0swJIzxD0LJKMFy-skxbhT-MWpXAzkrSsjHVa5khweEqi7EygY_tazSyEDlRlZsvY5uAciW22YqK0Y4ECaAIhXESKDoq0xlq9001ndSJvMuhyHF9mkB_pVy3w3poKvqtAj5i5t7_37dvw_MsmAu654zuQG_xa-l2kbsW-kNjbn8BUsEirw priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlZ3db9MwEMBPoxMCHvhmCwwUJN5otjp2E-dxDKYxiTEJOsaT5c-1okqnrQWNv56znQQK08Re8pBcJPty9v0cn-8AXvkkUvHXW4EXRpzNlM1dpkqdlziepKP-oPCHg2JvxPaPh8crULRnYULQfkhpGabpNjps6xwdjT8MhksnBAakQlwCGncDVoshMngPVkcHh9tffSU5ZJQMMSFvTsgMKL_k5SUvFJL1X0aY_wZKdruld-DWoj6VFz_kdPqHQ9q9B1_arsQ4lG-bi7na1D__yvJ4_b7eh7sNo6bbUfIBrNj6IdyMVSsvHsFRzHjcTJPpzKU7H4_ev81IlX6XWk_i_8V0UqfjLrgs9fFfSJr-7qfx5ESmh77ASdi_6Kf76LHrxzDaffd5Zy9ryjNkGrFunjmkDem0LUrpENENc5JbZYgZcskKrayjRHPChtQxxR1xg0oirJUWGdRwpugT6NWz2q5DKksptRoQbQxlFVcVswNFmMuLAKEuAdJ-LqGb3OW-hMZUhD10ykXUmUCdiaAzQRN43b1zGjN3XCn9xltBJ-mzbocbs7MT0XwZgXhLcss1dxRBzkhOcXlMc2UkdowYmcBGa0OimQrORY6EiKs4SqsEXnaPcRD7nRlZ29kiynhUrFBmLZpc1xIkjNIX3kmgXDLGpaYuP6kn45AovBryAte_CfRbs_3drKtU0e9M-z809_R64s_gdu4tG91_TjagNz9b2OfIdXP1ohnEvwBzSEU8 priority: 102 providerName: Unpaywall |
| Title | Effectiveness of COVID-19 vaccination in healthcare workers in Shiga Prefecture, Japan |
| URI | https://link.springer.com/article/10.1038/s41598-022-22682-3 https://www.ncbi.nlm.nih.gov/pubmed/36271136 https://www.proquest.com/docview/2727118339 https://www.proquest.com/docview/2727639999 https://pubmed.ncbi.nlm.nih.gov/PMC9586956 https://www.nature.com/articles/s41598-022-22682-3.pdf https://doaj.org/article/05412e8c8f3643da8384032bdaa611da |
| UnpaywallVersion | publishedVersion |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: HH5 dateStart: 20110101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: KQ8 dateStart: 20110101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: ABDBF dateStart: 20121221 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DIK dateStart: 20110101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: RPM dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVAQT databaseName: Springer Nature - nature.com Journals - Fully Open Access customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: NAO dateStart: 20111201 isFulltext: true titleUrlDefault: https://www.nature.com/siteindex/index.html providerName: Nature Publishing – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20210101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20210101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2045-2322 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M48 dateStart: 20110801 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: HAS SpringerNature Open Access 2022 customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: AAJSJ dateStart: 20111201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: C6C dateStart: 20111201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3db9MwEMBP-xACHhDfBEYVJN5ooI7dxHlAqCubRqWVitGpe7Jsx14rVenoWqD_Pec4DVRUE-IllWxHcu273O_8cQfw2gWR8ktvCT4YsSZSJraRSnWcoj5JS91F4dN-cjJkvVF7tAPrdEfVAF5vde1cPqnhfPr257fVB1T49_7KOH93jUbIXRRDtwphAomR7sI-WqrMpXI4rXDfx_qOM0ay6u7M9lc37FMZxn8be_59hLLeR70Lt5fFlVz9kNPpH6bq-D7cqxgz7HiheAA7pngIt3zWydUjOPcRi6vPXDizYffz-aePEcnC71LriV8fDCdFOK4Ph4Xu_BaSois9G08uZThwCUrK_Ydm2EOLWzyG4fHR1-5JVKVXiDRi2SKySAvSapOk0iJi58xKblRO8jaXLNHKWEo0J6xNLVPcEtvKJMJWapAhc84UfQJ7xawwzyCUqZRatYjOc8oyrjJmWoowGyclRNoAyHpQha5ij7sUGFNR7oFTLvxECJwIUU6EoAG8qd-58pE3bmx96OaqbumiZpcFs_mlqJRQIJ6S2HDNLUUQyyWn6N7SWOUS_xjJZQAH65kWa0kUMRIeemGUZgG8qqtRCd3OiizMbOnbONTLsM1TLxh1T5AQUpc4J4B0Q2Q2urpZU0zGZaDvrM0T9F8DaK6F63e3bhqKZi2A_zByz_-7Xy_gTuw0By15TA5gbzFfmpeIaAvVgN10lDZgv9PpnfXw9_CoP_iCpd2k2yiXPRqlZmLNsD_oXPwCVKE-ZA |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTWjwgPgmMCBI8ESj1bGbOA8TYl9q91Em2Ka9GTu210pVUtaWqf8cfxvnfI0KVPGylzwkTuTch-93Pt8dwHtXRKrceovwwog1gTKhDVSchjHqk7TUJQof96PuGTu46FyswK86F8Ydq6zXxGKh1nnq9sg3QzS0CIYpTT6NfwSua5SLrtYtNGTVWkFvFSXGqsSOQzO_RhdustXbRX5_CMP9vdOdblB1GQhSRCfTwKLRlDY1USwtIk3NrORGaaI7XLIoVcZSknLCOtQyxS2x7UQi5ogNQinNmaL43TuwxihL0Plb297rn3xtdnlcHI2RpMrWaVO-OUGL6bLa0AdE5IPwli5YxKJxwL_Q7t-HNpvI7X1Yn2VjOb-Wo9EfxnH_ITyoUK3_uRTDR7Bissdwt-xzOX8C52WN5Gph9XPr73w57-0GJPF_Ik2H5Y6kP8z8QXMczXcnxhCburvfBsNL6Z-4lihFxKPlH6CNz57C2a2Q-hmsZnlmXoAvYylT1Sap1kh4rhJm2oowG0YFbLUekJqoIq2qnbumGyNRRN0pFyUjBDJCFIwQ1IOPzTvjstbH0tHbjlfNSFenu7iRX12KSu0FAmISGp5ySxH6ackpOtQ0VFrijxEtPdioOS2qxWMibkTdg3fNY1R7F8uRmcln5RgHLhMc87wUjGYmiEli16rHg3hBZBamuvgkGw6K0uJJh0foMXvQqoXrZlrLSNFqBPA_KPdy-U-_hfXu6fGROOr1D1_BvdCpCoKFkGzA6vRqZl4jCpyqN5Wq-fD9trX7N7l-bMI |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VIl4HxJuFAkaCE1klXju73gNC0BA1LZRK0Co3Y3vtJlK0CU1Clb_Gr2O8rxKBIi697MHrXdmeGc83nvEMwCufRKo8eovxwamzobaRC3ViogTlSTnmLwp_Poz3jvn-sDvcgl_1XRgfVlnvicVGnU2NPyNvR6hoEQwzlrZdFRZx1Ou_m_0IfQUp72mty2mULHJgV-dovs3fDnpI69dR1P_4bXcvrCoMhAaRySJ0qDCVMzZOlEOUmXGnhNUZzbpC8dho6xg1gvIuc1wLR10nVYg3EoswKhNcM_zvFbia4Kh8OGEyTJrzHe9B4zSt7ul0mGjPUVf6-2xo_SHmQWDL1nRhUTLgXzj373DNxmd7C24s85lanavJ5A-12L8Dtys8S96XDHgXtmx-D66VFS5X9-GkzI5cbalk6sjul5NBL6Qp-amMGZdnkWSck1ETiEZ8rBiiUt_6dTQ-VeTIF0MpfB0tso_aPX8Ax5ey0A9hO5_m9jEQlShldIeaLGM8FTrltqMpd1FcAFYXAK0XVZoqz7kvtzGRhb-dCVkSQiIhZEEIyQJ403wzK7N8bOz9wdOq6ekzdBcN07NTWQm8RChMIyuMcAxBX6YEQ1OaRTpTODGaqQB2akrLatuYywsmD-Bl8xoF3ntxVG6ny7KPh5Up9nlUMkYzEkQjiS_SE0CyxjJrQ11_k49HRVLxtCtitJUDaNXMdTGsTUvRahjwP1buyeZJv4DrKNPy0-Dw4CncjLykIEqI6A5sL86W9hnCv4V-XsgZge-XLdi_AbJ9alw |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlZ3db9MwEMBPoxMCHvhmCwwUJN5otjp2E-dxDKYxiTEJOsaT5c-1okqnrQWNv56znQQK08Re8pBcJPty9v0cn-8AXvkkUvHXW4EXRpzNlM1dpkqdlziepKP-oPCHg2JvxPaPh8crULRnYULQfkhpGabpNjps6xwdjT8MhksnBAakQlwCGncDVoshMngPVkcHh9tffSU5ZJQMMSFvTsgMKL_k5SUvFJL1X0aY_wZKdruld-DWoj6VFz_kdPqHQ9q9B1_arsQ4lG-bi7na1D__yvJ4_b7eh7sNo6bbUfIBrNj6IdyMVSsvHsFRzHjcTJPpzKU7H4_ev81IlX6XWk_i_8V0UqfjLrgs9fFfSJr-7qfx5ESmh77ASdi_6Kf76LHrxzDaffd5Zy9ryjNkGrFunjmkDem0LUrpENENc5JbZYgZcskKrayjRHPChtQxxR1xg0oirJUWGdRwpugT6NWz2q5DKksptRoQbQxlFVcVswNFmMuLAKEuAdJ-LqGb3OW-hMZUhD10ykXUmUCdiaAzQRN43b1zGjN3XCn9xltBJ-mzbocbs7MT0XwZgXhLcss1dxRBzkhOcXlMc2UkdowYmcBGa0OimQrORY6EiKs4SqsEXnaPcRD7nRlZ29kiynhUrFBmLZpc1xIkjNIX3kmgXDLGpaYuP6kn45AovBryAte_CfRbs_3drKtU0e9M-z809_R64s_gdu4tG91_TjagNz9b2OfIdXP1ohnEvwBzSEU8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effectiveness+of+COVID-19+vaccination+in+healthcare+workers+in+Shiga+Prefecture%2C+Japan&rft.jtitle=Scientific+reports&rft.au=Chano%2C+Tokuhiro&rft.au=Yamashita%2C+Tomoko&rft.au=Fujimura%2C+Hirokazu&rft.au=Kita%2C+Hiroko&rft.date=2022-10-21&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=12&rft_id=info:doi/10.1038%2Fs41598-022-22682-3&rft.externalDocID=PMC9586956 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |